SAURABH SOMVANSHI: Open Payments
NPI 1891147047 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $50 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $215 |
| Neurocrine BioSciences, Inc. | 1 | $108 |
| Vanda Pharmaceuticals Inc. | 1 | $65 |
| Otsuka America Pharmaceutical, Inc. | 1 | $52 |
Products named: UZEDY, INGREZZA, FANAPT, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
